Dual biologic therapy with ocrelizumab for multiple sclerosis and vedolizumab for Crohn’s disease: A case report and review of literature

Figure 1 Repeat magnetic resonance enterography (original images). A: Axial T2 image demonstrating bowel wall thickening (arrowheads) and T2 hyperintensity within the bowel wall (arrow), consistent with mural oedema; B: Coronal contrast-enhanced T1 fat-suppressed image demonstrating mural hyperenhancement (arrowhead) and extensive mesenteric vascular congestion, known as the ‘comb sign’ (arrows).

Figure 2 Timeline of events. MS: Multiple sclerosis; MDT: Multidisciplinary Team; MRE: Magnetic resonance enterography.